Cancer cell associated glycans as targets for immunotherapy

por Vankemmelbeke, Mireille, Chua, Jia Xin, Durrant, Lindy G.
Publicado 2015

Current Strategies to Enhance Anti-Tumour Immunity

por Cook, Katherine W., Durrant, Lindy G., Brentville, Victoria A.
Publicado 2018

High Avidity Cytotoxic T Lymphocytes Can Be Selected into the Memory Pool but They Are Exquisitely Sensitive to Functional Impairment

por Brentville, Victoria A., Metheringham, Rachael L., Gunn, Barbara, Durrant, Lindy G.
Publicado 2012

Therapeutic Targeting of Lewis(y) and Lewis(b) with a Novel Monoclonal Antibody 692/29

por Noble, Philip, Spendlove, Ian, Harding, Stephen, Parsons, Tina, Durrant, Lindy G.
Publicado 2013

Cancer Vaccines, Adjuvants, and Delivery Systems

por Paston, Samantha J., Brentville, Victoria A., Symonds, Peter, Durrant, Lindy G.
Publicado 2021

Susceptibility to SARS-CoV-2 omicron following ChAdOx1 nCoV-19 and BNT162b2 versus CoronaVac vaccination

por Chua, Jia Xin, Durrant, Lindy Gillian, Chok, Yin Ling, Lai, Oi Ming
Publicado 2022

High expression of Lewis(y/b )antigens is associated with decreased survival in lymph node negative breast carcinomas

por Madjd, Zahra, Parsons, Tina, Watson, Nicholas FS, Spendlove, Ian, Ellis, Ian, Durrant, Lindy G
Publicado 2005

The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer

por Duncan, Timothy J, Watson, Nicholas FS, Al-Attar, Ahmad H, Scholefield, John H, Durrant, Lindy G
Publicado 2007

Combination Treatment with an Antibody–Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer

por Wan, Y. Louise, Sapra, Puja, Bolton, James, Chua, Jia Xin, Durrant, Lindy G., Stern, Peter L.
Publicado 2019

Correction to: Combination Treatment with an Antibody–Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of O...

por Wan, Y. Louise, Sapra, Puja, Bolton, James, Chua, Jia Xin, Durrant, Lindy G., Stern, Peter L.
Publicado 2019

Citrullinated Epitopes Identified on Tumour MHC Class II by Peptide Elution Stimulate Both Regulatory and Th1 Responses and Require Careful Selection for Optimal Anti-Tumour Respon...

por Symonds, Peter, Marcu, Ana, Cook, Katherine W., Metheringham, Rachael L., Durrant, Lindy G., Brentville, Victoria A.
Publicado 2021

Evidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: A tissue microarray study of 460 patients

por Watson, Nicholas FS, Madjd, Zahra, Scrimegour, Duncan, Spendlove, Ian, Ellis, Ian O, Scholefield, John H, Durrant, Lindy G
Publicado 2005

SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors

por Xue, Wei, Brentville, Victoria A., Symonds, Peter, Cook, Katherine W., Yagita, Hideo, Metheringham, Rachael L., Durrant, Lindy G.
Publicado 2016

Citrullinated α-enolase is an effective target for anti-cancer immunity

por Cook, Katherine, Daniels, Ian, Symonds, Peter, Pitt, Tracy, Gijon, Mohamed, Xue, Wei, Metheringham, Rachael, Durrant, Lindy, Brentville, Victoria
Publicado 2017

Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla

por Storr, Sarah J, Zaitoun, Abed M, Arora, Arvind, Durrant, Lindy G, Lobo, Dileep N, Madhusudan, Srinivasan, Martin, Stewart G
Publicado 2012

SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade

por Xue, Wei, Metheringham, Rachael L., Brentville, Victoria A., Gunn, Barbara, Symonds, Peter, Yagita, Hideo, Ramage, Judith M., Durrant, Lindy G.
Publicado 2016

High mobility group protein B1 is a predictor of poor survival in ovarian cancer

por Machado, Lee R., Moseley, Paul M., Moss, Robert, Deen, Suha, Nolan, Christopher, Spendlove, Ian, Ramage, Judith M., Chan, Stephen YT., Durrant, Lindy G.
Publicado 2017

A Novel HAGE/WT1-ImmunoBody(®) Vaccine Combination Enhances Anti-Tumour Responses When Compared to Either Vaccine Alone

por Almshayakhchi, Rukaia, Nagarajan, Divya, Vadakekolathu, Jayakumar, Guinn, Barbara-Ann, Reeder, Stephen, Brentville, Victoria, Metheringham, Rachael, Pockley, A. Graham, Durrant, Lindy, McArdle, Stephanie
Publicado 2021

PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy

por Choudhury, Ruhul H, Symonds, Peter, Paston, Samantha J, Daniels, Ian, Cook, Katherine W, Gijon, Mohamed, Metheringham, Rachael L, Brentville, Victoria A, Durrant, Lindy G
Publicado 2022

Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity

por Shah, Sabaria, Cook, Katherine W, Symonds, Peter, Weißer, Juliane, Skinner, Anne, Al Omari, Abdullah, Paston, Samantha J, Pike, Ian, Durrant, Lindy G, Brentville, Victoria A
Publicado 2023